Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Myelodysplastic Syndromes 11Leukemia, Myeloid, Acute 11Anemia, Refractory, with Excess of Blasts 10Leukemia 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Lymphoma 6Lymphoma, Non-Hodgkin 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Biphenotypic, Acute 4Hematologic Neoplasms 4Congenital Abnormalities 4Burkitt Lymphoma 4Blast Crisis 4Anemia, Refractory 4Primary Myelofibrosis 3Myeloproliferative Disorders 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Immunologic Deficiency Syndromes 3Histiocytosis 3Anemia, Sickle Cell 3Anemia, Aplastic 3Waldenstrom Macroglobulinemia 2Thrombocythemia, Essential 2

Interventions

fludarabine 3fludarabine phosphate 2Cyclophosphamide 2AP 1903 reagent 2thymoglobulin 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Rituximab 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Melphalan 1Erythrocyte Count 1Dexamethasone 1Clofarabine 1Bortezomib 1Blood Transfusion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thalassemia × Thiotepa × Classical hematology × Clear all
NCT03609840 2023-09-21

Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡